SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-20-017531
Filing Date
2020-10-05
Accepted
2020-10-05 09:12:24
Documents
1
Period of Report
2020-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3/A doc1.html 3/A  
1 FORM 3/A doc1.xml 3/A 2995
  Complete submission text file 0001567619-20-017531.txt   4456
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address
Lin Patrick (Reporting) CIK: 0001799363 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39531 | Film No.: 201222448